L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer

NCT00754767 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped unable to accrue study participants

Conditions

Breast Cancer
Chemotherapeutic Agent Toxicity
Neurotoxicity

Interventions

DRUG: L-carnitine L-tartrate
OTHER: placebo

Sponsor

HealthPartners Institute